INVESTIGATION OF THE CLINICAL COURSE AND SEVERITY OF COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS

Ozturk S., Kant A., Comoglu S., Ertunc B., YILMAZ G.

ACTA MEDICA MEDITERRANEA, vol.37, no.5, pp.2593-2597, 2021 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 5
  • Publication Date: 2021
  • Doi Number: 10.19193/0393-6384_2021_5_400
  • Journal Name: ACTA MEDICA MEDITERRANEA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Page Numbers: pp.2593-2597
  • Keywords: COVID-19, SARS-CoV-2, Immunocompromise, Hematological malignancies, Clinical Course, Severity
  • Karadeniz Technical University Affiliated: Yes

Abstract

Introduction: Immunocompromised patients, SARS-CoV-2 infection might have a more severe course and may cause pneumonia quicker, compared to normal hosts. The presence of comorbid diseases increases this risk even further. In our study, we aimed to determine the clinical course and severity of COVID-19 in immunocompromised patients.